Zobrazeno 1 - 10
of 132
pro vyhledávání: '"MMA Faridi"'
Autor:
Ravishankar Ramachandran, Vivek Bhosale, Himanshu Reddy, Virendra Atam, MMA Faridi, Jalees Fatima, Vaibhav Shukla, Zaw A Khan, Hana Khan, Vikram Singh, Mahendra Pal Singh Negi, Mukesh Srivastava, Ajay Kumar Srivastava, Chandra Bhushan Tripathi, Nayan Ghosh, Nilanjana Majumdar, Raj Kamal Tripathi, Srikanta Kumar Rath, Prabhat Ranjan Mishra, Sharad Sharma, Tapas K Kundu
Publikováno v:
International Journal of Infectious Diseases, Vol 115, Iss , Pp 62-69 (2022)
Objective: To test efficacy, safety and tolerability of Umifenovir in non-severe COVID-19 adult patients. Methods: We carried out randomized, double-blind, placebo-controlled, multicenter, phase III trials involving adult (18-75 years), non-severe CO
Externí odkaz:
https://doaj.org/article/dcd93c210c8347afac38aa1f14db76ae
Autor:
Nitin Shah, MMA Faridi, Monjori Mitra, Ashish Bavdekar, Archana Karadkhele, Gaurav Puppalwar, Rishi Jain
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 16, Iss 11, Pp 2816-2821 (2020)
Hepatitis A represents one of the major public health problems worldwide including India. Vaccination is the most effective way to prevent hepatitis A infection. Two types of hepatitis A vaccines-live attenuated (H2 strain) and inactivated (killed) a
Externí odkaz:
https://doaj.org/article/0dbe5bfb29d541c28ac29ea5842e1758
Publikováno v:
Indian Journal of Neonatal Medicine and Research, Vol 2, Iss 1, Pp 1-6 (2014)
Background: Septicaemia is the single most important cause of neonatal morbidity and mortality in the world, accounting for over half of the cases. Aim: This study was conducted to establish the clinical and bacteriological profile in newborns wi
Externí odkaz:
https://doaj.org/article/d20cdeb84eea4403b1c752b7259d48f6
Publikováno v:
Journal of Global Infectious Diseases, Vol 6, Iss 3, Pp 132-134 (2014)
Fatal-disseminated Bacillus Calmette Guerin (BCG) disease is well known in infants with severe combined immunodeficiency after BCG vaccination. We report a 7 month male infant delivered as a product of in vitro fertilization and twin gestation that p
Externí odkaz:
https://doaj.org/article/0b7ee34e870c4de6b1c98b1ec031e767
Publikováno v:
Journal of Paediatrics and Child Health. 58:2248-2253
Non-pharmacological methods are commonly used to reduce the procedural pain in newborns. In this open label, randomised control trial, we studied the pain-reducing effect of kangaroo mother care (KMC) during orogastric tube insertion.Newborns, with b
WHO recommendations for the management of Community Acquired Pneumonia (CAP) have been revised since 2014, amoxicillin is recommended as first choice for oral antibiotic therapy in domiciliary treatment of children. This study was planned to compare
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::301255ced422dd3de9b7deecb4b029b2
Publikováno v:
INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH. :22-25
Objectives: To measure and compare the levels of anticardiolipin(aCL), anti-β2-glycoprotein 1(aβ2gp1) and antinuclear(ANA) antibodies in children with idiopathic epilepsy, epilepsy due to neurocysticercosis (NCC) and healthy controls and to find th
Publikováno v:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-7 (2020)
BackgroundChildren living with sputum smear-positive adult tuberculosis (TB) patients are vulnerable to acquire tubercular infection. Contact tracing is an important strategy to control tubercular infection in the community. This study was done to fi
Autor:
Nayan Ghosh, Zaw A Khan, Raj Kamal Tripathi, Himanshu Reddy, Ravishankar Ramachandran, Mma Faridi, Srikanta Kumar Rath, Sharad Sharma, Chandra Bhushan Tripathi, Virendra Atam, Jalees Fatima, Mahendra Pal Singh Negi, Prabhat Ranjan Mishra, Vaibhav Kumar Shukla, Hana Khan, Vivek Bhosale, Tapas K Kundu, Vikram Singh, Ajay Kumar Srivastava, Mukesh Srivastava, Nilanjana Majumdar
Publikováno v:
International Journal of Infectious Diseases
International Journal of Infectious Diseases, Vol 115, Iss, Pp 62-69 (2022)
International Journal of Infectious Diseases, Vol 115, Iss, Pp 62-69 (2022)
Objective To test efficacy, safety and tolerability of Umifenovir in non-severe COVID-19 adult patients. Methods We carried out randomized, double-blind, placebo-controlled, multicenter, phase III trials involving adult (18-75 years), non-severe COVI
Publikováno v:
Annals of Pathology and Laboratory Medicine. 6:A185-190
Background: Birth asphyxia, though not always a recognizable cause, is a well documented contributor to perinatal and neonatal mortality. Four million babies are born asphyxiated annually resulting into 20% of all neonatal deaths. Perinatal asphyxia